Error
  • The template for this display is not available. Please contact a Site administrator.

Food Allergy

Rationale: The use of Internet and, particularly, social media, has dramatically increased in recent years. Patients and healthcare providers are using social media as a source of information on Food Allergy. However, reliability of the available information is controversial.
Aims: To assess the quality of the information on Food Allergy available on the Twitter Social Media platform and its possible impact on the work of health care professionals and the management of patients with food allergy.
Methods: Retrospective, observational study of a of tweets published in 2019 with hashtags related to Food Allergy. Analysis wil combine an artificial intelligence-powered engine (Symplur Signals, Symplur LLC, California), with the manual review of a sample of tweets.

Interest Group: Food Allergy
Chair: Alberto Alvarez-Perea
Secretary: Alexandra Figueira Santos
There has been growing interest from patients, healthcare professionals and the public about food allergy with fatalities hitting the headlines. Questions about the threshold of reactivity and food allergen labelling remain often unanswered and guidance is required to inform the recommendations given to food allergic patients and their families. This task force will review recently published studies about food allergen thresholds, specifically: how thresholds are determined, factors which can impact on food allergen threshold and biomarkers to predict threshold; and will elaborate a position paper on the basis of this evidence to support the clinical care provided to food allergic patients, namely allergen doses that should be given to diagnose and treat food allergies, recommendations about which foods need to be avoided and which foods can be safely eaten by food allergic patients and food allergen labelling.

Interest Group: Food Allergy
Chair: Paul Turner
Secretary: Alexandra Santos

Picture1

Food allergy is a field where significant therapeutic improvements have been achieved in the last decade. In the last EAACI guidelines on Food AIT, this therapeutic modality was found to be effective to desensitize patients in milk, egg and peanut allergy. Beyond the concept of desensitization, in almost every trial, different thresholds are preestablished to define what will be considered a therapeutic success or failure of the intervention. This heterogeneity in outcomes definitions seriously jeopardizes the comparability of results from different sources.

Objectives:

Evaluate clinical efficacy outcomes of Food AIT.

Understand how the use of different outcomes can impact on the reported efficacy of food AIT trials.

To identify clinical outcomes relevant for patients

Produce recommendations on what efficacy outcomes are to be used in future AIT trials

Current structure:

In order to achieve these objectives, the work has been splitted into 3 different packages:

WP1: Literature review to evaluate what clinical efficacy outcomes have been used so far and make a comprehensive evaluation of the pros/cons of each of them

WP2: Assessment of the impact of using different definitions of efficacy (linked to WP 1) in a set of real patients who participated in previous peanut OIT trials.

WP3: Patient´s survey to gather patient´s perspective on their view of Food AIT relevant clinical outcomes

Section: EAACI Pediatric Section

Chair: Pablo Rodríguez del Río; Secretary: Montserrat Fernandez Rivas

Members: Paul Turner; Stefania Arasi; Raphaëlle Bazire; Brian Vickery; Katharina Blümchen; Audrey Dunn Galvin; Antoine Deschildre, Carmelo Escudero; Giovanni Pajno; Sabine Schnadtt; Marta Vázquez-Ortiz; Wesley Burks; Anna Nowak-Wegrzyn; Matthew Greenhawt; Carmen Riggioni; Nandinee Patel